Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population.

OBJECTIVE To estimate the prevalence, incidence, survival, and disease characteristics of systemic sclerosis (SSc) in the Detroit tricounty area. METHODS A census of SSc cases for the period 1989-1991 was conducted in the Detroit area, using multiple sources for case identification. Diagnoses were verified by medical record review. Capture-recapture analysis was used to estimate the total SSc population. Cases of localized scleroderma (morphea and linear disease) were excluded. RESULTS Based on 706 verified cases of SSc, prevalence was initially estimated to be 242.0 cases per million adults (95% confidence interval [95% CI] 213-274), with an annual incidence of 19.3 new cases per million adults per year (95% CI 12.4-30.2). Capture-recapture analysis, based on the degree of overlap of verified cases among multiple sources, resulted in a revised prevalence estimate of 276 cases per million adults (95% CI 245-310). Sex- and race-specific prevalence estimates were significantly higher for women than for men, and for blacks than for whites. The average age at diagnosis was significantly younger for blacks than for whites. Compared with white patients, black patients were almost twice as likely to have diffuse disease (prevalence proportion ratio 1.86, 95% CI 1.48-2.35). Median survival was approximately 11 years. Factors negatively affecting survival included male sex (hazard ratio 1.81, 95% CI 1.29-2.55) and older age at diagnosis (hazard ratio 1.04, 95% CI 1.03-1.05). CONCLUSION This study establishes baseline estimates of SSc occurrence and characteristics in a large US cohort consisting primarily of black adults and white adults. These data should facilitate research regarding the role of geographic, ethnic, racial, and environmental factors for this disease in comparison populations.

[1]  V W Sidel,et al.  Capture-recapture methods for assessing the completeness of case ascertainment when using multiple information sources. , 1974, Journal of chronic diseases.

[2]  K. Davis,et al.  Systemic sclerosis prevalence and mortality in Sydney 1974-88. , 1999, Australian and New Zealand journal of medicine.

[3]  J. D. McNeil,et al.  South Australian scleroderma register: Analysis of deceased patients , 1998, Pathology.

[4]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[5]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[6]  J. Reveille,et al.  HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis). , 1999, Tissue antigens.

[7]  Y. Ikeda,et al.  Initial predictors of survival in patients with systemic sclerosis (scleroderma). , 1992, The Keio journal of medicine.

[8]  A. Wiik,et al.  Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. , 2001, The Journal of rheumatology.

[9]  A. Silman.  Scleroderma--demographics and survival. , 1997, The Journal of rheumatology. Supplement.

[10]  É. Rich,et al.  Predicting Mortality in Systemic Sclerosis: Analysis of a Cohort of 309 French Canadian Patients with Emphasis on Features at Diagnosis as Predictive Factors for Survival , 2002, Medicine.

[11]  Jerald F. Lawless,et al.  Statistical Models and Methods for Lifetime Data. , 1983 .

[12]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[13]  A. Masi,et al.  Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. , 1971, Annals of internal medicine.

[14]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[15]  W. Hauser,et al.  Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn., 1951 through 1967, with special reference to systemic lupus erythematosus. , 1969, Mayo Clinic proceedings.

[16]  J. Reveille,et al.  Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. , 1996, Arthritis and rheumatism.

[17]  M. Mayes,et al.  Racial differences in scleroderma among women in Michigan. , 1997, Arthritis and rheumatism.

[18]  J. Reveille,et al.  Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. , 2001, Seminars in arthritis and rheumatism.

[19]  M. Weinrich,et al.  Prevalence of scleroderma spectrum disorders in the general population of South Carolina. , 1989, Arthritis and rheumatism.

[20]  A. Silman.  Mortality from scleroderma in England and Wales 1968-1985. , 1991, Annals of the rheumatic diseases.

[21]  D. Buskila,et al.  Mortality in systemic sclerosis (scleroderma). , 1992, The Quarterly journal of medicine.

[22]  S. Bombardieri,et al.  Systemic Sclerosis: Demographic, Clinical, and Serologic Features and Survival in 1,012 Italian Patients , 2002, Medicine.

[23]  L. Elveback,et al.  Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. , 1985, Mayo Clinic proceedings.

[24]  R R Regal,et al.  The value of capture-recapture methods even for apparent exhaustive surveys. The need for adjustment for source of ascertainment intersection in attempted complete prevalence studies. , 1992, American journal of epidemiology.

[25]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[26]  A. Masi,et al.  The epidemiology of systemic sclerosis (scleroderma) among male U.S. veterans. , 1978, Journal of chronic diseases.

[27]  K. Steinsson,et al.  Systemic sclerosis in Iceland. A nationwide epidemiological study. , 1994, Annals of the rheumatic diseases.

[28]  T. Medsger,et al.  Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982. , 1997, Arthritis and rheumatism.

[29]  R R Regal,et al.  Accuracy of alternative approaches to capture-recapture estimates of disease frequency: internal validity analysis of data from five sources. , 2000, American journal of epidemiology.

[30]  J. Walker,et al.  Scleroderma in South Australia: epidemiological observations of possible pathogenic significance , 2001, Internal medicine journal.

[31]  D. Bloch,et al.  Predictors of survival in systemic sclerosis (scleroderma). , 1991, Arthritis and rheumatism.

[32]  A. Silman,et al.  An epidemiological study of scleroderma in the West Midlands. , 1988, British journal of rheumatology.

[33]  M. Mayes,et al.  The design of a population-based case-control study of systemic sclerosis (scleroderma): commentary on the University of Michigan study. , 1995, Journal of clinical epidemiology.

[34]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[35]  K. Takehara,et al.  Epidemiological study of patients with systemic sclerosis in Tokyo , 2004, Archives of Dermatological Research.

[36]  G. Littlejohn,et al.  A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease. , 1988, The Journal of rheumatology.

[37]  A. Masi,et al.  Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients. , 1973, Journal of chronic diseases.

[38]  A. Masi,et al.  Epidemiology of systemic sclerosis (scleroderma). , 1971, Annals of internal medicine.